Kyoto University’s CiRA (Director, Dr. Yamanaka) Purchases Fluidigm Corporation BioMark(TM) System for Stem Cell Reprogramming Research

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation today announced that the Center for iPS Cell Research and Application (CiRA; Director Dr. Shinya Yamanaka) of Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS), has introduced a BioMark™ System for Genetic Analysis. CiRA is using the unique microfluidic properties of the system’s integrated fluidic circuits (IFCs) to analyze selected genes in iPS (induced pluripotent stem) cells and quantify copies of specific genes transferred into a cell to generate iPS cells.

MORE ON THIS TOPIC